Start Date
November 23, 2020
Primary Completion Date
November 23, 2020
Study Completion Date
November 23, 2020
TMV-018 + 5-FC
"TMV-018: liquid frozen, life attenuated, oncolytic measles virus encoding the prodrug converting enzyme super cytosine deaminase; 1E+06 TCID50 to 1E+08 TCID50 per dose.~5-FC: 150 mg/kg/day for 2 days during each treatment."
TMV-018 + anti-PD-1
"TMV-018: liquid frozen, life attenuated, oncolytic measles virus encoding the prodrug converting enzyme super cytosine deaminase; 1E+06 TCID50 to 1E+08 TCID50 per dose.~Anti-PD-1 inhibitor dose according to its SMPC."
TMV-018 + 5-FC + anti-PD-1
"TMV-018: liquid frozen, life attenuated, oncolytic measles virus encoding the prodrug converting enzyme super cytosine deaminase; 1E+06 TCID50 to 1E+08 TCID50 per dose.~5-FC: 150 mg/kg/day for 2 days during each treatment cycle.~Anti-PD-1 Inhibitor: dose according to its SMPC."
University Hospital Bonn, Bonn
University Hospital Tübingen, Tübingen
Collaborators (1)
Assign Data Management and Biostatistics GmbH
OTHER
Optimapharm
INDUSTRY
Themis Bioscience GmbH
INDUSTRY